Dark

SPHS
Sophiris Bio, Inc. Common Stock
stock OTC

Inactive

Nov 5, 2021

0.000100USD0.000%(0.000000)78,055

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

open chart

Headquarters

CA, USA

Industry

Biotechnology

Last Split

Aug 15, 20131for52.0021reverse

KERX LLY PFE MRK MRTX NYMX XLV

Profile

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in research and development of products for the treatment of urological diseases. It is developing topsalysin (PRX302) for treatment of benign prostatic hyperplasia.